Cargando…
Could COVID-19 anosmia and olfactory dysfunction trigger an increased risk of future dementia in patients with ApoE4?
The association of the coronavirus disease 2019 (COVID-19) with significant neurological and neuropsychiatric complications has been increasingly reported, both during the acute illness and in its aftermath. However, due to the short duration of patient follow up until now, it is not clear whether t...
Autores principales: | Manzo, Ciro, Serra-Mestres, Jordi, Isetta, Marco, Castagna, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7785277/ https://www.ncbi.nlm.nih.gov/pubmed/33422806 http://dx.doi.org/10.1016/j.mehy.2020.110479 |
Ejemplares similares
-
Behavioral, Psychiatric, and Cognitive Adverse Events in Older Persons Treated with Glucocorticoids
por: Manzo, Ciro, et al.
Publicado: (2018) -
Depression and depressive symptoms in patients with polymyalgia rheumatica: discussion points, grey areas and unmet needs emerging from a systematic review of published literature
por: Manzo, Ciro, et al.
Publicado: (2020) -
The Role of Tumor Necrosis Factor Alpha Antagonists (Anti TNF-α) in Personalized Treatment of Patients with Isolated Polymyalgia Rheumatica (PMR): Past and Possible Future Scenarios
por: Manzo, Ciro, et al.
Publicado: (2022) -
Cognitive Function in Primary Sjögren’s Syndrome: A Systematic Review
por: Manzo, Ciro, et al.
Publicado: (2019) -
Polymyalgia rheumatica and polymyalgia-like syndromes as adverse events following COVID-19 vaccines: working notes from a narrative review of published literature
por: Manzo, Ciro, et al.
Publicado: (2022)